Scientists create genetic ‘pen’ that corrects common heart conditions
By Manuel Ansede,
El País
| 01. 15. 2023
The gene editing techniques that have revolutionized medicine since 2016 could also be used to treat common heart diseases, the number one cause of death in humans, according to a study published recently by one of the world’s leading scientists, Eric Olson, from the US. His team was able to modify two letters – or bases – of the approximately 3 billion that make up the DNA of a mouse. This change was enough to silence a protein linked to multiple cardiovascular problems. Olson is cautious, but highlights the potential advantages of this new strategy: since heart cells last a lifetime, it is only a matter of making the change once.
DNA is like a recipe book for making proteins, the minuscule machines that take care of the main tasks in a living being: carrying oxygen through the blood, fighting viruses, digesting food. That manual is written with four letters, repeated millions of times: ATGGCGAGTTGC… each of these letters is the initial of a chemical compound with different amounts of carbon, hydrogen, nitrogen and oxygen: adenine (C₅H₅N₅), cytosine (C₄H₅N₃O)... see more
Related Articles
Gene therapy has been the next big thing in medicine for decades. Until recent years, the results were underwhelming. Now there are promising developments and real successes, but significant questions remain: Is it safe enough? How many people might benefit, and under what conditions? And, crucially, how much will gene therapies cost and who will pay?
It has been more than 50 years since gene therapy was formally proposed; more than 40 years since the first scandal; more than 30...
By CGS Staff
| 01.14.2023
Photo by Isabela Kronemberger on Unsplash
Throughout 2022, CGS worked to deepen and expand collaborations with advocates and scholars concerned about the social justice implications of a range of human biotechnologies, with a major focus on the alarming prospect of using genome editing in human reproduction. We also organized and sponsored public events; curated, analyzed, and commented on news related to human genetics and assisted reproduction, both in media outlets and in our own newsletter and social media; and conducted...
By Emily Sohn, Nature | 01.09.2023
Each day, around 350 people in the United States die from lung cancer. Many of those deaths could be prevented by screening with low-dose computed tomography (CT) scans. But scanning millions of people would produce millions of images, and there...
By Antonio Regalado, MIT Technology Review | 01.11.2023
I met the entrepreneur Martine Rothblatt for the first time at a meeting at West Point in 2015 that was dedicated to exploring how technology might expand the supply of organs for transplant. At any given time, the US transplant...
